Literature DB >> 23081931

Amido-bridged nucleic acids (AmNAs): synthesis, duplex stability, nuclease resistance, and in vitro antisense potency.

Aiko Yahara1, Ajaya Ram Shrestha, Tsuyoshi Yamamoto, Yoshiyuki Hari, Takashi Osawa, Masaki Yamaguchi, Masaru Nishida, Tetsuya Kodama, Satoshi Obika.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23081931     DOI： 10.1002/cbic.201200506

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  11 in total

1.  Evaluation of multiple-turnover capability of locked nucleic acid antisense oligonucleotides in cell-free RNase H-mediated antisense reaction and in mice.

Authors:  Tsuyoshi Yamamoto; Naoko Fujii; Hidenori Yasuhara; Shunsuke Wada; Fumito Wada; Naoya Shigesada; Mariko Harada-Shiba; Satoshi Obika
Journal:  Nucleic Acid Ther       Date:  2014-04-23       Impact factor: 5.486

2.  Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways.

Authors:  Tomohiro Yamasaki; Takahiro Horie; Satoshi Koyama; Tetsushi Nakao; Osamu Baba; Masahiro Kimura; Naoya Sowa; Kazuhisa Sakamoto; Kazuhiro Yamazaki; Satoshi Obika; Yuuya Kasahara; Jun Kotera; Kozo Oka; Ryo Fujita; Takashi Sasaki; Akihiro Takemiya; Koji Hasegawa; Kenji Minatoya; Takeshi Kimura; Koh Ono
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

Review 3.  In vitro selection of BNA (LNA) aptamers.

Authors:  Masayasu Kuwahara; Satoshi Obika
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

4.  Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.

Authors:  Yuichiro Aiba; Jiaxin Hu; Jing Liu; Qin Xiang; Carlos Martinez; David R Corey
Journal:  Biochemistry       Date:  2013-11-27       Impact factor: 3.162

5.  Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.

Authors:  Takuya Uehara; Chi-Jing Choong; Masayuki Nakamori; Hideki Hayakawa; Kumiko Nishiyama; Yuuya Kasahara; Kousuke Baba; Tetsuya Nagata; Takanori Yokota; Hiroshi Tsuda; Satoshi Obika; Hideki Mochizuki
Journal:  Sci Rep       Date:  2019-05-21       Impact factor: 4.379

6.  A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.

Authors:  Masahito Shimojo; Yuuya Kasahara; Masaki Inoue; Shin-Ichi Tsunoda; Yoshie Shudo; Takayasu Kurata; Satoshi Obika
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

7.  GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.

Authors:  Shinji Matsumoto; Taku Yamamichi; Koei Shinzawa; Yuuya Kasahara; Satoshi Nojima; Takahiro Kodama; Satoshi Obika; Tetsuo Takehara; Eiichi Morii; Hiroomi Okuyama; Akira Kikuchi
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

Review 8.  Development of Antisense Drugs for Dyslipidemia.

Authors:  Tsuyoshi Yamamoto; Fumito Wada; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2016-07-27       Impact factor: 4.928

9.  Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes.

Authors:  Kiyoko Setoguchi; Lin Cui; Nobutaka Hachisuka; Sumalee Obchoei; Kentaro Shinkai; Fuminori Hyodo; Kiyoko Kato; Fumito Wada; Tsuyoshi Yamamoto; Mariko Harada-Shiba; Satoshi Obika; Kenji Nakano
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-14

10.  Synthesis and Evaluation of Artificial Nucleic Acid Bearing an Oxanorbornane Scaffold.

Authors:  Hibiki Komine; Shohei Mori; Kunihiko Morihiro; Kenta Ishida; Takumi Okuda; Yuuya Kasahara; Hiroshi Aoyama; Takao Yamaguchi; Satoshi Obika
Journal:  Molecules       Date:  2020-04-09       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.